Clinical Trials at Cabrini Hospital; Cabrini Foundation
During the past decade, Cabrini Hospital; Cabrini Foundation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cabrini Hospital; Cabrini Foundation"
#1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Cabrini Hospital; Cabrini Foundation
According to Clinical.Site data, the most researched conditions in "Cabrini Hospital; Cabrini Foundation" are
"Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "Cabrini Hospital; Cabrini Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Cabrini Hospital; Cabrini Foundation
Most popular intervention types in "Cabrini Hospital; Cabrini Foundation" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "Abemaciclib" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cabrini Hospital; Cabrini Foundation
The vast majority of trials in "Cabrini Hospital; Cabrini Foundation" are
2 trials for "Female" genders.
Clinical Trials Status at Cabrini Hospital; Cabrini Foundation
Currently, there are NaN active trials in "Cabrini Hospital; Cabrini Foundation".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Cabrini Hospital; Cabrini Foundation,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cabrini Hospital; Cabrini Foundation, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".